I agree. At the moment it is hard even for me to find negatives.
-We are holding at current levels with reasonable shares being traded and no obvious dumping.
-Just completed a placement at current price, no discount.
-Now funded for an additional year on top of what we already had.
-Ceo and Cso appointed, both with what appear to be solid cridentials.
-Cso linked to Janssens, a previous partner??
-Cso very interested in continuing his previous work on trying to "drug the undruggable" using technology it appears only we can provide.
-Data pack shortly for proprietry myc inhibitor with demonstratable cell penetration and endosomal escape ability.
-Several non disclosure agreements in place covering who knows what other applications for cpp's.
-start of new financial year shortly, Any tax balancing by holders likely finished
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)